President Donald Trump’s latest bid to slash prescription drug prices has once again stirred heated debate about the high costs paid by U.S. patients.

The White House called out prominent Democrats for allegedly failing to deliver on promises to lower prescription drug prices, accusing them of protecting a system that favors pharmaceutical companies ...

On May 12th the president signed an executive order that seeks to force drugmakers to reduce their prices in America to align ...

COLA may be the smallest increase in five years, but inflation trends could shift that outlook. Here's what we know now.

Shares of Halozyme Therapeutics (NASDAQ:HALO) remained under pressure on Wednesday as Morgan Stanley downgraded the developer of Enhanze drug delivery technology, citing a faster timeline for the ...

Cardiff Oncology's onvansertib shows promise as a first-in-class PLK1 inhibitor for first-line RAS-mutated metastatic ...

Although initially started as a microscope and camera maker 100 years ago, Olympus is now a dedicated medical device company focusing on endoscopic and surgical solutions. We expect Olympus to enjoy ...